...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Detection of Circulating Tumor Cells in Bladder Cancer Using Multiplex PCR Assays
【24h】

Detection of Circulating Tumor Cells in Bladder Cancer Using Multiplex PCR Assays

机译:多重PCR检测膀胱癌中循环肿瘤细胞的方法

获取原文
获取原文并翻译 | 示例

摘要

Aim: The aim of this study was to develop multiplex-PCR assays for the detection of circulating tumor cells in peripheral blood and urine samples of patients with bladder cancer. Materials and Methods: Peripheral blood and urine samples were collected from 208 patients (169 patients and 39 healthy volunteers). After RNA extraction and cDNA synthesis, the samples were analyzed for the expression of cytokeratin 19 (CK19), CK20 and epidermal growth factor receptor (EGFR) mRNA in blood and for SURVIVIN, human telomerase reverse transcriptase (hTERT), cytokeratin 20 (CK20) mRNA in urine, using multiplex-PCR assays. Results: EGFR and CK20 alone or in combination as well as all urine markers correlated W ell with histological grade. hTERT correlated well with primary tumor size T >= 3. Patients with positive urine markers had significantly worse progression-free survival. Conclusion: Multiplex-PCR assays can be a useful tool for staging and monitoring purposes in patients with bladder cancer.
机译:目的:本研究的目的是开发用于检测膀胱癌患者外周血和尿液样本中循环肿瘤细胞的多重PCR检测方法。材料与方法:收集了208例患者(169例患者和39名健康志愿者)的外周血和尿液样本。经过RNA提取和cDNA合成后,分析样品中血液中细胞角蛋白19(CK19),CK20和表皮生长因子受体(EGFR)mRNA的表达以及SURVIVIN,人端粒酶逆转录酶(hTERT),细胞角蛋白20(CK20)的表达。使用多重PCR检测尿液中的mRNA。结果:单独使用或联合使用的EGFR和CK20以及所有尿液标记物均将Well与组织学分级相关。 hTERT与原发肿瘤大小T> = 3密切相关。尿液标记阳性的患者的无进展生存期明显较差。结论:多重PCR检测可以作为膀胱癌患者分期和监测目的的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号